Skip to main content

Table 1 Baseline characteristics of study population at the time of COVID-19 diagnosis

From: Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic

 

Whole Cohort (n = 48,066)

 

Hospitalized (n = 9,681)

 
 

Control (n = 47,187)

Anticoagulation (n = 879)

P-value

Control (n = 9,352)

Anticoagulation (n = 329)

P-value

Age, yrs

59.0 (43.0, 71.0)

72.0 (67.0, 78.0)

< 0.01

69.0 (59.0, 76.0)

73.0 (69.0, 80.0)

< 0.05

Race

 White

31616 (67.0)

669 (76.1)

< 0.01

5472 (58.5)

221 (67.2)

< 0.05

 Black

14275 (30.3)

196 (22.3)

3646 (39.0)

100 (30.4)

 Other

1296 (2.7)

14 (1.6)

234 (2.5)

8 (2.4)

Sex

 Male

38337 (81.2)

855 (97.3)

< 0.01

8677 (92.8)

319 (97.0)

< 0.05

Smoking

 Current

7115 (15.1)

102 (11.6)

< 0.01

1657 (17.7)

41 (12.5)

< 0.05

 Former

10386 (22.0)

343 (39.0)

2738 (29.3)

126 (38.3)

 Never

19163 (40.6)

400 (45.5)

4170 (44.6)

143 (43.5)

Comorbidities

 HPL

25277 (53.6)

744 (84.6)

< 0.01

6513 (69.6)

273 (83.0)

< 0.05

 COPD

7560 (16.0)

362 (41.2)

< 0.01

2710 (29.0)

159 (48.3)

< 0.05

 CHF

4715 (10.0)

386 (43.9)

< 0.01

2107 (22.5)

180 (54.7)

< 0.05

 CAD

7205 (15.3)

412 (46.9)

< 0.01

2592 (27.7)

170 (51.7)

< 0.05

 MI

2374 (5.0)

145 (16.5)

< 0.01

1067 (11.4)

80 (24.3)

< 0.05

 DM

14819 (31.4)

499 (56.8)

< 0.01

4546 (48.6)

200 (60.8)

< 0.05

 HTN

25710 (54.5)

807 (91.8)

< 0.01

7200 (77.0)

310 (94.2)

< 0.05

 PAD

1939 (4.1)

94 (10.7)

< 0.01

804 (8.6)

42 (12.8)

< 0.05

 CAS

1520 (3.2)

94 (10.7)

< 0.01

587 (6.3)

40 (12.2)

< 0.05

 CKD

5442 (12.1)

289 (32.9)

< 0.01

2461 (26.3)

161 (48.9)

< 0.05

 AVR/MVR

2194 (4.6)

190 (21.6)

< 0.01

839 (9.0)

91 (27.7)

< 0.05

 DVT

1212 (2.6)

158 (18.0)

< 0.01

518 (5.5)

61 (18.5)

< 0.05

 PE

612 (1.3)

110 (12.5)

< 0.01

270 (2.9)

54 (16.4)

< 0.05

 VTE

1577 (3.3)

222 (25.3)

< 0.01

671 (7.2)

95 (28.9)

< 0.05

Medications

 Aspirin

3641 (7.7)

116 (13.2)

< 0.01

1222 (13.1)

60 (18.2)

< 0.05

 Insulin

2976 (6.3)

153 (17.4)

< 0.01

986 (10.5)

66 (20.1)

< 0.05

 Statin

10689 (22.7)

536 (61.0)

< 0.01

2974 (31.8)

194 (59.0)

< 0.05

  1. Data are presented as number (%) for categorical variables and mean (IQR) for continuous variables
  2. HPL Hyperlipidemia, COPD Chronic obstructive pulmonary disease, CHF Congestive heart failure, CAD Coronary artery disease, MI Myocardial infarction, DM Diabetes mellitus, HTN Hypertension, PAD Peripheral arterial disease, CAS Carotid artery stenting, CKD Chronic kidney disease, AVR/MVR Aortic valve replacement/ mitral valve repair, DVT Deep vein thrombosis, PE Pulmonary embolism, VTE Venous thromboembolism